Novel pharmacological effects of poly (ADP-ribose) polymerase inhibitor rucaparib on the lactate dehydrogenase pathway

MLA

Kohji Noguchi, et al. “Novel Pharmacological Effects of Poly (ADP-Ribose) Polymerase Inhibitor Rucaparib on the Lactate Dehydrogenase Pathway.” Biochemical and Biophysical Research Communications, vol. 510, no. 4, Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fc52bb534702a98a3a77a64dfa99fc9b&authtype=sso&custid=ns315887.

APA

Kohji Noguchi, Yuma Nonomiya, Yoshikazu Sugimoto, & Kazuhiro Katayama. (2019). Novel pharmacological effects of poly (ADP-ribose) polymerase inhibitor rucaparib on the lactate dehydrogenase pathway. Biochemical and Biophysical Research Communications, 510(4).

Chicago

Kohji Noguchi, Yuma Nonomiya, Yoshikazu Sugimoto, and Kazuhiro Katayama. 2019. “Novel Pharmacological Effects of Poly (ADP-Ribose) Polymerase Inhibitor Rucaparib on the Lactate Dehydrogenase Pathway.” Biochemical and Biophysical Research Communications 510 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fc52bb534702a98a3a77a64dfa99fc9b&authtype=sso&custid=ns315887.